Clinical Trial Update: Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas [Phase 1]

View source ↗

Summary

Phase 1 study update for INBRX-109 in locally advanced or metastatic solid tumors including Ewing sarcoma. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• INBRX-109 (INBRX-109)

Snippet

Sponsor: Inhibrx Biosciences, Inc | Conditions: Ewing Sarcoma | Phase 1 | Status: RECRUITING